Alpha Teknova (TKNO) Non-Current Deferred Tax Liability (2020 - 2026)
Alpha Teknova (TKNO) posted quarterly Non-Current Deferred Tax Liability of $925000.0 for Q1 2026, up 9.08% year-over-year from $848000.0 in Q1 2025, and up 5.23% quarter-over-quarter from $879000.0 in Q4 2025.
Alpha Teknova (TKNO) Non-Current Deferred Tax Liability (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has reported Non-Current Deferred Tax Liability for 7 consecutive years, with $925000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability rose 9.08% year-over-year to $925000.0; the TTM figure through Mar 2026 stood at $925000.0 (up 9.08% YoY), while the FY2025 annual figure was $879000.0, up 6.29% from the prior year.
- Non-Current Deferred Tax Liability improved to $925000.0 in Q1 2026 per TKNO's latest filing, from $879000.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $2.8 million in Q1 2022 and bottomed at $827000.0 in Q4 2024.
- Historically, Non-Current Deferred Tax Liability has averaged $1.2 million across 5 years, with a median of $925000.0 in 2026.
- Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability plunged 61.21% — and 2025, when it advanced 9.11%.
- Alpha Teknova's Non-Current Deferred Tax Liability stood at $1.2 million in 2022, then decreased by 24.86% to $919000.0 in 2023, then fell by 10.01% to $827000.0 in 2024, then rose by 6.29% to $879000.0 in 2025, then climbed by 5.23% to $925000.0 in 2026.
- Business Quant data shows TKNO's Non-Current Deferred Tax Liability at $925000.0 in Q1 2026, $879000.0 in Q4 2025, and $946000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Alpha Teknova | 396.90 Mn | 379.46 Mn | 4.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 956,000.00 |
| Jun 30, 2026 | 956,000.00 |
| Mar 31, 2026 | 925,000.00 |
| Mar 31, 2026 | 925,000.00 |
| Dec 31, 2025 | 879,000.00 |
| Dec 31, 2025 | 879,000.00 |
| Sep 30, 2025 | 946,000.00 |
| Sep 30, 2025 | 946,000.00 |
| Jun 30, 2025 | 868,000.00 |
| Jun 30, 2025 | 868,000.00 |
| Mar 31, 2025 | 848,000.00 |
| Mar 31, 2025 | 848,000.00 |
| Dec 31, 2024 | 827,000.00 |
| Dec 31, 2024 | 827,000.00 |
| Sep 30, 2024 | 867,000.00 |
| Sep 30, 2024 | 867,000.00 |
| Jun 30, 2024 | 875,000.00 |
| Jun 30, 2024 | 875,000.00 |
| Mar 31, 2024 | 884,000.00 |
| Mar 31, 2024 | 884,000.00 |